Navigation Links
Bernstein Liebhard LLP Launches Pradaxa Lawsuit Website Providing Information on Mounting Pradaxa Litigation, Side Effects
Date:1/20/2013

New York, NY (PRWEB) January 20, 2013

Bernstein Liebhard LLP has launched a new Pradaxa lawsuit website dedicated to informing the public about the harmful side effects that may stem from the blood thinner manufactured by Boehringer-Ingelheim Pharmaceuticals Inc. The information provided by the firm’s new Pradaxa website is vital to anyone seeking to file a Pradaxa lawsuit.

Bernstein Liebhard LLP is currently offering free and confidential Pradaxa lawsuit evaluations to patients who have sustained the following injuries:

  •     Gastrointestinal (stomach) bleeding;
  •     Cerebral hemorrhaging (bleeding in the brain);
  •     Severe internal bleeding following a minor trauma, such as a fall; or
  •     Death from serious internal bleeding.

“We are receiving more and more inquiries from people who claim to have suffered life-threatening Pradaxa bleeding side effects. Our new website will help provide information about potential Pradaxa side effects, as well as updates on the mounting number of Pradaxa lawsuits being filed by people around the U.S.," says Bernstein Liebhard LLP, a nationwide law firm representing the victims of drugs and medical devices.

Pradaxa, a blood thinner prescribed to reduce the risk of stroke and embolism in patients with non-valvular atrial fibrillation, was approved by the U.S. Food and Drug Administration (FDA) in 2010. In 2011, the FDA received reports of 3,781 side effects and 542 deaths tied to the blood thinner, according to a recent article from Bloomberg.com.*

Patients with artificial heart valves were recently found to be at a heightened risk for suffering Pradaxa side effects. Following this revelation, the FDA issued a public health communication on December 19, 2012 informing health care providers and the public that Pradaxa should not be used to prevent stroke or blood clots in patients with mechanical heart valves. The agency also announced that all health care providers would be receiving “Dear Doctor Letters” from the company alerting them of this change.**

Pradaxa Lawsuits
A number of Pradaxa lawsuits have already been filed on behalf of patients who experienced side effects associated with the drug. These Pradaxa lawsuits have since been consolidated into the multidistrict litigation, In re: Pradaxa Product Liability Litigation (“MDL No. 2385”) underway in the U.S. District Court for the Southern District of Illinois and are pending before Judge David R. Herndon. According to a report in the Madison Record, 176 Pradaxa lawsuits were pending in this MDL as of Jan. 10, 2013.***

Patients who took Pradaxa and suffered excessive bleeding side effects may be entitled to file a Pradaxa lawsuit to receive compensation for lost wages, medical expenses, as well as any pain and suffering they may have been caused as a result of their injury. Learn more about Pradaxa side effects by visiting Bernstein Liebhard LLP’s website, http://www.consumerinjurylawyers.com/ or by contacting a lawyer at Bernstein Liebhard LLP today at (877) 779-1414.

*bloomberg.com/news/2012-12-11/boehringer-sued-by-hundreds-over-bleeding-tied-to-pradaxa.html
**fda.gov/Drugs/DrugSafety/DrugSafetyPodcasts/ucm333209.htm
***madisonrecord.com/issues/895-product-liability/251351-herndon-reports-steady-progress-in-yaz-pradaxa-litigation

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com

Read the full story at http://www.prweb.com/releases/pradaxa-lawsuit/pradaxa-bleeding/prweb10340318.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Actos Bladder Cancer Lawsuits: Next Status Conference in Federal Actos Litigation Scheduled for January 24, 2013, Bernstein Liebhard LLP Reports
2. Pradaxa Side Effect Problems Continue, as New Report Finds Pradaxa Bleeding More Likely to Result in Death, Bernstein Liebhard LLP Reports
3. Bernstein Liebhard LLP Launches Mirena IUD Lawsuit Website Providing Information on Side Effects, Growing Litigation
4. Da Vinci Surgery Robot Lawsuit Website Launched by Bernstein Leibhard LLP to Inform Public about Potential Da Vinci Surgery Complications
5. 176 Pradaxa Lawsuits Now Pending in Federal Litigation, Discovery Well Underway, Bernstein Liebhard LLP Reports
6. GranuFlo Lawsuit Consolidation Supported by Fresenius Medical Care, Bernstein Liebhard LLP Reports
7. Stryker Hip Recall Lawsuits Being Evaluated by Bernstein Liebhard LLP, Following Recall of Stryker Rejuvenate and ABG II Modular Neck Stems
8. DePuy ASR Hip Recall, Transvaginal Mesh Lawsuit Updates: Bernstein Liebhard LLP Looks Forward to Start of First Bellwether Trials in New Year
9. Propecia Lawsuits Being Investigated by Bernstein Liebhard LLP, as Propecia Litigation Pending in New Jersey Superior Court Continues to Move Forward
10. Pradaxa Lawsuits Being Investigated by Bernstein Liebhard LLP, as Next Conference in Federal Pradaxa Litigation Set for January 10th
11. New Metal-on-Metal Hip Implant Study Emphasizes Importance of Patients’ Symptoms in Evaluating the Need for Hip Replacement Revisions, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work to ... “patient engagement.” The patient is doing more than filling out a survey; in many ... is an increasing emphasis in health care and research on the importance of active ...
(Date:10/13/2017)... ... 13, 2017 , ... The International Association of Eating Disorders ... for the field of eating disorders, announces the opening of early registration for ... Florida at the Omni Resort at ChampionsGate. , The annual iaedp™ ...
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & ... and special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to ... with elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded ...
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset ... of specialty vendors and unique items from across the nation, this holiday-themed event will ... services offered by the VNA. The boutique will be open Saturday, November 4 ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Yisrayl Hawkins, ... week that explains one of the most popular and least understood books in the ... cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed it ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 Diplomat Pharmacy, ... 8th Day Software and Consulting, LLC , and named ... 8th Day Software, based in Tennessee , ... 8th Day expands EnvoyHealth,s service offerings for health care ... "In an interoperable ...
(Date:9/28/2017)... 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), will ... and webcast on Friday, November 3, 2017, beginning at ... at approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... financial performance and guidance for 2018, Hill-Rom executives will ... operational performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
Breaking Medicine Technology: